InsidersTradesSigma
Total declarations
Company
▲ Purchases (11 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Levy Noah G., Director. Officer active across 1 company, notably Merrimack Pharmaceuticals INC. In total, 11 reports have been logged. Breakdown: 11 buys · 0 sell. Total volume traded: €357k. History available since 7 January 2022. The latest transaction was filed on 16 June 2022 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations11 total
297 shares@ US$5.4480.4% of flowCommon StockSEC:0000899243-22-023332:0
Ideal exit: 13 Mar 2023 (T+270)
11,977 shares@ US$5.173316.6% of flowCommon StockSEC:0000899243-22-022785:0
Ideal exit: 11 Mar 2023 (T+270)
3,653 shares@ US$4.92064.7% of flowCommon StockSEC:0000899243-22-022373:0
Ideal exit: 7 Mar 2023 (T+270)
1,505 shares@ US$4.47681.7% of flowCommon StockSEC:0000899243-22-003837:0
Ideal exit: 25 Oct 2022 (T+270)
1,505 shares@ US$4.47684.3% of flowCommon StockSEC:0000899243-22-003837
Ideal exit: 25 Oct 2022 (T+270)
19,528 shares@ US$5.007462.0% of flowCommon StockSEC:0000899243-22-003553
Ideal exit: 23 Oct 2022 (T+270)
19,528 shares@ US$5.007424.2% of flowCommon StockSEC:0000899243-22-003553:0
Ideal exit: 23 Oct 2022 (T+270)
8,719 shares@ US$3.834421.1% of flowCommon StockSEC:0000899243-22-001744
Ideal exit: 7 Oct 2022 (T+270)
8,719 shares@ US$3.83448.2% of flowCommon StockSEC:0000899243-22-001744:0
Ideal exit: 7 Oct 2022 (T+270)
5,215 shares@ US$3.818212.6% of flowCommon StockSEC:0000899243-22-001470
Ideal exit: 4 Oct 2022 (T+270)
5,215 shares@ US$3.81824.9% of flowCommon StockSEC:0000899243-22-001470:0
Ideal exit: 4 Oct 2022 (T+270)
11 of 11 declarations
About Levy Noah G.
Noah G. Levy is a Board Member at Merrimack Pharmaceuticals Inc. He participates in strategic decision-making and oversight of the company's operations. With a strong background in the pharmaceutical sector, Levy brings valuable insights to the board, contributing to innovation and growth at Merrimack.
